424B3: Prospectus
EFFECT: Others
S-3: Registration statement for specified transactions by certain issuers
PRE 14A: Preliminary proxy statements relating to merger or acquisition
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(4.9%),Anson Management GP LLC(4.9%), etc.
8-K: ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
10-Q: Q3 2024 Earnings Report
8-K: Current report
8-K: Current report
8-K: Current report
424B5: Prospectus
424B3: Prospectus
424B3: Prospectus
EFFECT: Others
EFFECT: Others
CORRESP: CORRESP
CORRESP: CORRESP
UPLOAD: Others
UPLOAD: Others
DEFA14A: Others
No Data